EMFs and Brain Tumours
[Home Page]
[Leukaemia]
[Brain Tumours]
[Electromagnetic Sensitivity]
[Microwave Sickness]
[Other Health Effects]
There has been repeated coverage in the last few years that mobile phones
will increase your chances of getting both malignant and benign forms of brain
tumours. There has been vehement criticism of this coverage, claiming that there
is no scientific evidence to support such an association, and that reporting a
link is inappropriate at best, irresponsible scaremongering at worst.
In actual fact, there is now a large amount of epidemiological literature
assessing the risk of mobile phone usage and brain cancer. In reality we would
not expect studies to have found a link at this point in time, as the latency
period (time between exposure to cause and diagnosis of cancer) of most brain
tumours is between 15 and 25 years, and mobile phones have only been in
widespread usage for about 10 years.
Despite this, a number of papers are now showing signs of a significantly
increased risk of brain cancer incidence from long term usage (over 10 years)
have now been published:
Lennart Hardell and Swedish Research
Oncologist Lennart Hardell and his colleagues has been researching this
association for about 10 years and has published numerous papers covering their
findings. Starting with preliminary work at the turn of the century where they
found a statistically significant 1.4-fold increase in risk for brain tumours
(not sub-categorised) on the same side of the head as the mobile phone was
used[Hardell 1999, Hardell
2000].
In 2002, looking at 1617 patients histopathologically diagnosed with brain
tumours, they found that use of analogue mobile phones was associated with a
significant 30% increase in risk for brain tumours (overall). This increased to
80% when only looking at patients who had used their phone for over 10 years,
and further to 150% (2.5 times as likely to develop a brain tumour) when side of
the head was taken into account. For acoustic neuromas, the increase in risk was
250% [Hardell 2002]. This was followed in 2003 by
a separate analysis that found that Astrocytomas also had a significantly
increased risk of 80%[Hardell Feb 2003], and a
subsequent paper finding a 3.5-fold risk of Acoustic Neuroma from mobile phone
use (CI 1.77-6.76)[Hardell Mar 2003]
By 2005 most papers generally sub-categorised brain tumour risk from mobile
phone usage into acoustic neuromas, meningiomas and gliomas. Hardell produced a
paper in 2005 analysing the increase in risk for acoustic neuromas and
meningiomas. With a very good response rate (85%) he found that, for a mobile
phone usage of greater than 10 years, the odds ratio for meningiomas was 2.1 (CI
1.1-4.3) and for acoustic neuromas this was split further into digital mobile
phones (2.0 - CI 1.05-3.8) and analogue mobile phones (4.2 - CI 1.8-10)[Hardell 2005]. By this stage his results were
consistantly pointing towards a possible doubling in risk, and this for mobile
phone users who had not used their phone for as long as the typical latency
period for the tumours! Hardell also published one of the only papers to date
looking at risk of non-hodgkin's lymphoma, finding a 6-fold increase for over 10
years of use. He did highlight however that there were very few cases and that
the results should be interpreted with a fair degree of caution[Hardell Sept 2005].
In February 2006 Hardell published a paper using more recent diagnoses
(patients diagnosed between 2000 and 2003), and found that the increase in risk
was steadily strengthening in magnitude and statistical significance as the
length of phone usage was increasing. For malignant tumours he found that the
OR for analogue phone use was 2.6 (CI 1.5-4.3), for digital phone use was 1.9
(CI 1.3-2.7), and for cordless phone use was 2.1 (CI 1.4-3.0). Looking at
patients who had used their phones for 10 years or more this increased to 3.5
(CI 2.0-6.4), 3.6 (CI 1.7-7.5) and 2.9 (CI 1.6-5.2) respectively[Hardell Feb 2006]. This work was followed up in October
2006 looking specifically at acoustic neuromas (a benign form of brain tumour),
astrocytomas and non-hodgkin's lymphomas. He found acoustic neuromas and the
higher grades of astrocytoma (Grades III and IV) to have significant increases
from all forms of mobile and cordless phone usages (around 50% increase in risk
in each case), which increased further for those who had used their phone
greater than 10 years. However, he found no increase for lower grade
astrocytomas (Grade I and II), and no increase for non-hodgkin's
lymphomas in contrast to his paper from the previous year[Hardell Oct 2006].
Hardell's published a meta-analysis in September 2007 of the existing
literature to date (2 cohort studies and 16 case-control studies). His findings
were a 140% increase in risk for benign acoustic neuromas (CI 1.1-5.3) and a
100% increase in risk for malignant gliomas (CI 1.2-3.4), with further increased
risks when looking at ipsilateral exposure[Hardell Sept
2007]. His summary so far on all the work (including work from othor
researchers) is that "Results from present studies on use of mobile phones for
> or =10 years give a consistent pattern of increased risk for acoustic
neuroma and glioma. The risk is highest for ipsilateral exposure.
Flaws, Recall Bias and Selection Bias
As he is one of the only researchers consisently finding an effect, he has
received a lot of criticism for the expected quality (or lack of) his work. The
primary criticism that has been directed at his work is that of recall bias
(failure of the mobile phone users to correctly remember the amount of usage and
the side of the head). However (and primarily for the Interphone study), this
has been addressed by Vrijheid in a study that found that heavy users generally
overestimated their use and light users generally underestimated their use[Vrijheid 2006]. As the high risk category is the heavy
users, an overestimation of use would imply the risk is actually attributed to
lower usage, which will lead to an underestimation of risk. Vrijheid also
found a small element of inaccuracy of users recalling which side of the head
their phone used which may contribute to an slight overestimation of risk in the
highest user category[Vrijheid 2008]. The other
Interphone study to look at recall bias found that users were more accurate at
recalling phone usage in terms of number of calls made than total phone usage,
but without comment as to how this was likely to effect the reported
risk[Samkange-Zeeb 2004]. One of the Interphone
papers looked at selection bias, and found that approximately 10% less cases
responded than controls (70% and 80% response rates respectively)[Lahkola 2005]. If this difference is real, it would lead
to an overestimation in risk, but it is only based on one of the Interphone
studies and Lloyd Morgan's pooled analysis found only 60% of controls responded
on average (See the section on flaws of the Interphone Project below) - if so,
this would instead lead to an underestimation in risk.
The Interphone Project
The Interphone project, initiatied in 1999, is a multi-national initiative
aiming to fully examine the association between long term mobile phone usage
and increases in risk for all forms of brain cancer. The results of the project
were expected to be published in 2005, but the findings were conflicting and
the researchers involved in the project were divided into three opinions on how
the results should be summarised: a) that there was a possible increase in
brain tumour risk that is real and warrants further investigation, b) that
the increase is an artifact due to bias in the study, and c) that with the data
currently available it is not possible to tell whether a) or b) are correct,
with both being a feasible possibility. Louis Slesin has covered the various
updates in the Interphone project in great detail on his Microwave News website. The results of
the Interphone project have still (as of August 2008) not been published.
Unfortunately, here are a number of flaws with the design of the studies in
the Interphone project. One of the major flaws is a lack of inclusion in most of
the studies of any form of recognition of digital cordless phone users. With the
handset similar to a phone and the base unit exposing users all the time whilst
they are in the building, this becomes a very large confounder for using "length
of phone usage" as a metric of exposure level.
Lloyd Morgan, an American researcher and electronic engineer (and currently a
member of the board of directors at the Central
Brain Tumor Registry of the United States), has been writing about the
Interphone papers as each one is published, and has explained the major flaws
with the Interphone protocol in great detail in his column (though this is currently out of date - a new
update is currently being developed). The summary of the 6 primary flaws are
listed below:
Flaw 1: Selection Bias
The first flaw is called selection bias. It is likely the result of the low
percentage of controls that participated in the studies (weighted average of
59%). Think about being randomly selected for a cellphone study. You are told
you will be asked to answer a long questionnaire. If you use a cellphone you are
more likely to agree to participate than if you do not use a cellphone. If this
happens it is called selection bias. Selection bias will result in an
underestimation of risk.
Flaw 2: Inclusion of Tumors Outside the Cellphone's Radiation Plume
The second flaw is the inclusion of all brain tumors without regard to their
location. Because the cellphone's radiation plume only penetrates a short
distance into the head, nearly all of this radiation is absorbed by the temporal
lobe, the acoustic nerve, or the parotid gland. Even when cellphone exposure of
one side of the head is considered on the side where the cellphone was held, a
substantial portion of half the brain is unexposed (the opposite side is
completely unexposed). Studies that include brain tumors outside of the
cellphone radiation plume contribute to an underestimation of the risk of
brain tumors.
Flaw 3: Latency Time and Definition of Regular User
The third flaw is the definition of "regular" cellphone use in relation to a
reasonable latency time. "Regular" cellphone use is defined as use of a
cellphone on average once per week for at least 6 months. Exposure within 1 year
of the diagnosis date is not considered. The result of this definition, combined
with the incredibly fast rate of new cellphone users, is to overweight "regular"
users with an incredibly large group of short-term users - far too short a time
to expect a tumor to be diagnosed.
The latency time for brain tumors is between 15 and 25 years. For the
Interphone studies, using weighted averages for cases or controls, we see that
6.3% of cases and 6.4% of controls have used a cellphone for 10 years or more,
and 18% of cases and 21% of controls have used a cellphone for 5 years or more
(Weighted average of 10 Interphone brain tumor studies - 3 Interphone studies of
5 countries which the 10 studies are excluded). For a reasonable latency time,
it would be unlikely to find any risk of tumors, given the percentage of cases
and controls. Yet some of the Interphone studies are already finding a risk.
Because such a large percentage of "regular" users have used a cellphone for an
unreasonably short latency time the reported results for < 10 years as well
as for > 10 years (6.3% of cases) are an underestimation of risk.
Flaw 4: Children and Young Adult Are Not Included in Interphone Studies
The Interphone Protocol states that cases be between 30 and 59 years of age
While a few studies have included cases as young as 20, the non-inclusion of
< 20 year olds is likely to result in an underestimation of risk.
Research has shown that children's brains (due to skull formation through the
childhood years) absorb a greater proportion of the radiation emitted by a mobile
phone[Ghandi 1996, Ghandi 2002,
Christ 2005, de Salles 2006, Wiart 2008]. They are also likely to be at a greater
risk due to their higher rate of cell division (than adults). It is generally
accepted that teenagers and young adults are the primary users of mobile phones.
Flaw 5: Cellphone's Radiated Power
It is reasonable to expect that risk of a tumor from a cellphone, after a
reasonable latency time, would be the cellphone's power multiplied by cumulative
time of use. In the early days of cellphone use all cellphones used analog
technology. These always radiated a fixed amount of power (~2 Watts). Analog
cellphones use has been totally displaced by digital cellphones. Digital
cellphones have a feature called Automatic Power Control or APC. At the
beginning of a call the cellphone radiates maximum power (~2 Watts) but quickly
reduces the power so the radiated power is sufficient to have a reliable link to
the cell tower (AKA masks or base stations). The result is that cellphones
radiate far less power in urban areas compared to rural areas. This is because
cell phone towers are much closer in urban areas compared to rural areas so the
cellphone radiates less power in urban areas and more power in rural areas. When
rural and urban cellphones are not reported separately the result is an
underestimation of risk.
Flaw 6: Number of Cases Included in a Study
The weighted average time in these 10 studies for a case to be eligible for
inclusion in the study was only 2.6 years. When one considers 4 of the 5
previous flaws, it becomes obvious that such a short period of time for
eligibility will result in too few cases to resolve these flaws. For example, if
tumors were limited only to the exposed region of the brain then there would be
far fewer cases; if a reasonably long latency time was included, again there
would be far fewer cases; if children had been included there would have been
more cases; and, if rural users were to be compared to the far larger number of
urban users a much larger number of cases would need to be eligible to
participate in the Interphone Study.
In this year's (2008) BEMS (Bioelectromagnetics Society) meeting, Lloyd
presented a thorough
talk outlining all of these flaws, their implications, and how this
affected the statistical data represented in the papers. His indication that the
flaws in the Interphone protocol would significantly underestimate the overall
risk would closely match our
original theory as speculated in January 2007 when one of Lahkola's
studies[Lahkola 2007] was published, based on
crude statistical analysis of suspicious looking figures. Lahkola published a
meta-analysis of scandinavian papers in August 2008 that similar found these
strongly significant protective effects, with an OR 0.76 (CI 0.65-0.89)[Lahkola 2008]!
It wasn't just Lahkola's work though, a number of the Interphone studies
have found statistically significant protective effects from
mobile phone usage[Schuz Mar 2006, Schuz Dec 2006, Christensen 2005, Lonn
2005, Klaeboe 2007], and despite these flaws some
have still found statistically significant increase in risk for the heavier
group of mobile phone users[Hepworth 2006, Lonn Nov 2004, Schoemaker 2005, Takebayashi 2008, Hours 2007].
A number of the papers have not shown this unlikely looking protective
effect and have still not shown an increase[Christensen
2004, Takebayashi 2006], but it is important to
remember that with around 5% of the cases having used their phone for 10 years
or more we would not expect to see a risk anyway (as the latency period for
these tumours tends to be between 15 and 25 years). The fact that any papers are
showing a risk is very concerning.
Other Research
There have been a number of other issues on an individual study basis, such
as the highly publicised Danish cohort study towards the end of 2006[Schuz Mar 2006, Schuz Dec 2006]
which was hyped as being a "definitive study", containing some 400,000 people in
the dataset. Sadly, as we covered in great detail in December 2006, the classification of these
subjects was extremely misleading: Firstly, only contract users were considered
as those were the only users that it was possible to identify. All "pay as you
go" users were classified as "non-mobile phone users" and effectively moved into
the control group - this would lead to an underestimation of risk.
Originally the authors had 720,000 records, of which 100,000 were removed (quite
validly) due to duplication. Out of the remaining 620,000, a further 200,000
were removed because they "couldn't identify the users" as the contracts were
corporate and not linked to any specific individual. By the authors' own
admission these were likely to be the heaviest phone users in the dataset, so
another 33% of the heaviest users they were looking for were moved in to the
"non-user" control group, which would also lead to an underestimate the
risk. Strangely, the study's findings then highlighted a significant
protective effect (7 of the 18 data points had a statistically significant
reduction in risk), which disappeared in the highest usage category. One reason
for this may be the flaws detailed by Lloyd Morgan above for the Interphone
project papers, that would expect a significantly reduced OR in cases when
compared to controls. If these are controlled for in the statistical
calculations, we end up finding an increase in risk of 30% for the heaviest
users, reaching borderline significance!
There have been a number of other epidemiological papers published over the
last 10 years looking at mobile phones and brain cancer, but most of these have
failed to find an effect. This is unsurprising, as the studies were published
a number of years ago and the cases involved had used their phones for less than
5 years - far too short a period to find any risk of brain tumours[Lonn Jan 2004, Cook 2003, Muscat 2002, Johansen 2001, Inskip
2001, Muscat 2000, Auvinen
2002]. Despite this, two of the studies found increases for brain
cancer that were of borderline significance[Muscat
2000, Auvinen 2002]. More recently Kan performed
a meta-analysis on 9 case-control studies, finding no increase of risk overall
but a statistically significant increase in risk (OR 1.25) for those who have
used their phone for more than 10 years (CI 1.01-1.54)[Kan
2008].
References
2. P
Hardell L et al, (May 2000) Case-control study on radiology work, medical x-ray investigations, and use of cellular telephones as risk factors for brain tumors, MedGenMed. 2000 May 4;2(2):E2 [ View Author's abstract conclusions] [ View
on Pubmed]
6. P
Hardell L et al, (2005) Case-control study on cellular and cordless telephones and the risk for acoustic neuroma or meningioma in patients diagnosed 2000-2003, Neuroepidemiology. 2005;25(3):120-8 [ View Author's abstract conclusions] [ View
on Pubmed]
8. P
Hardell L et al, (February 2006) Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000-2003, Environ Res. 2006 Feb;100(2):232-41 [ View Author's abstract conclusions] [ View
on Pubmed]
15. -
Ghandi O, Kang G, (1996) Effect of the head size on SAR for mobile telephones at 835 and 1900MHz, Bioelectromagnetics Society 23rd Annual Meeting. St. Paul, Minnesota, USA, June 10-14, 2001, p. 52 [ View Author's abstract conclusions]
16. -
Ghandi O, Kang G, (May 2002) Some present problems and a proposed experimental phantom for SAR compliance testing of cellular telephones at
835 and 1900 MHz, Phys. Med. Biol. 47 1501 18 [ View Author's abstract conclusions] [ View
on Pubmed]
21. N
Lahkola A et al, (August 2008) Meningioma and mobile phone use--a collaborative case-control study in five North European countries, Int J Epidemiol. 2008 Aug 2. [Epub ahead of print]Click here to read [ View Author's abstract conclusions] [ View
on Pubmed]
29. P
Schoemaker MJ et al, (October 2005) Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries, Br J Cancer. 2005 Oct 3;93(7):842-8 [ View Author's abstract conclusions] [ View
on Pubmed]
30. N
Takebayashi T et al, (February 2008) Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study, Br J Cancer. 2008 Feb 12;98(3):652-9 [ View Author's abstract conclusions] [ View
on Pubmed]
31. -
Hours M et al, (October 2007) Cell Phones and Risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study, Rev Epidemiol Sante Publique. 2007 Oct;55(5):321-32 [ View Author's abstract conclusions] [ View
on Pubmed]
|